◀ Back to CD79A

CD79A — TBCA

Text-mined interactions from Literome

Pascual et al., Infect Immun 1999 (Escherichia coli Infections) : In the present study, mice orally immunized with a Salmonella vector engineered to stably express ETEC colonization factor antigen I (CFA/I) showed initially elevated serum IgG1 and mucosal IgA anti-CFA/I Ab responses
Jertborn et al., Clin Diagn Lab Immunol 2001 (Escherichia coli Infections) : The IgA ASC responses against CTB were significantly higher after the second than after the first immunization, whereas the CFA-specific IgA ASC responses were almost comparable after the first and second doses of ETEC vaccine
Pascual et al., J Immunol 2001 (Salmonella Infections, Animal...) : In L-Sel ( -/- ) mice, mucosal IgA anti-CFA/I fimbrial responses were greatly reduced, and systemic IgG2a anti-CFA/I fimbrial responses were 26-fold greater compared with C57BL/6 ( L-Sel ( +/+ ) ) mice
Vasu et al., Infection 2003 (Melioidosis) : Melioidosis patients generated a strong IgG, IgA and IgM response to the CFA of B. pseudomallei throughout the infection and IgG1 and IgG2 were the predominant IgG istotypes produced
Qadri et al., Vaccine 2006 : The IgA-antibody secreting cell (ASC) responses to CFA/I ( GM : 28.1 ASC/10 ( 7 ) PBMC ) and BS ( GM : 55.7 ASC/10 ( 7 ) PBMC ) were elevated compared to placebo recipients ( CFA/I-2.0 ; BS-4.8 ASC/10 ( 7 ) PBMC ) ( P = 0.01 to < 0.001 )
Lundgren et al., Vaccine 2013 : The prototype vaccine induced mucosal IgA ( fecal secretory IgA and intestine derived IgA antibody secreting cell ) responses to both LTB and CFA/I , as well as serum IgA and IgG antibody responses to LTB ... The higher dose of the prototype vaccine induced significantly higher fecal and systemic IgA responses to LTB and fecal IgA responses to CFA/I than the reference vaccine
Evans et al., FEMS Microbiol Immunol 1988 (Diarrhea...) : The data presented here suggest that for this vaccine preparation an intestinal anti-CFA/I IgA response is a good indicator of a protective immune response, which most likely involves antibody responses to a number of antigens in addition to CFA/I
Jertborn et al., Vaccine 1998 (Escherichia coli Infections) : The frequencies and magnitudes of CFA IgA ASC responses were similar when giving the vaccine with a 1 or 2 week interval